China Ming Yang Wind Power Group (NYSE:MY) announced this month that the Company signed a memorandum of understanding to cooperate on a series of proposed wind energy projects with the provincial government of Hebei, a province in Northern China. Mr. Chuanwei Zhang, Chairman and CEO of Ming Yang, commented, "We believe this cooperation with the Hebei government will enhance our ability to grow our business and further expand our market share in China."
China Ming Yang Wind Power Group Limited, through its subsidiaries, engages in the manufacture and sale of wind turbines and the provision of related maintenance services in the People?s Republic of China. It also involves in the research and development of wind turbine technology. The company sells its wind turbines to state-owned power producers, regional alternative energy investment companies, regional power producers, and privately owned wind farm operators.
Copper is a ductile metal, with very high thermal and electrical conductivity. Pure copper is rather soft and malleable, and a freshly exposed surface has a pinkish or peachy color. It is used as a thermal conductor, an electrical conductor, a building material, and a constituent of various metal alloys.
La Corona de Cobre Project
Global Hunter's La Corona de Cobre project is over 18,000 hectares of land located in the Coast Range of the Andean Cordillera, Chile, an area often referred to as the Chilean Iron Belt. The property is on the Pan American Highway, 70-kilometres north of the port city La Serena.
The property is located at the southern end of the Atacama Fault Zone, a north-northeast regional feature that stretches for over 1,000 kilometres and hosts several large copper deposits in Chile including Phelps Dodge's Candelaria (400 million tonnes grading 0.95% copper and 0.2% gold) and Anglo-American's Manto Verde (100 million tonnes averaging 0.80% copper) deposits.
- Over 18,000 hectare land package
- 70km North of La Serena, Chile (deep water port)
- Pan American Highway and major transmission lines pass through property
- Readily accessible water
- Railways adjacent to property
- 15 mineralized shear zones ranging from 20 to 250m in widths and 0.5 to 9.0km in length
- 1 of the 15 shear zones (Las Posadas), has been drill tested
Global Hunter's La Corona de Cobre hosts a swarm of 15 shear zones ranging from 10 to 150 metres in thickness and from one-half to nine-kilometres in length.
Global Hunter Corp. engages in the acquisition, exploration, and development of mineral properties in Canada and Chile. Global Hunter Corp. primarily explores for gold, copper, and base and precious metals. Global Hunter Corp. was founded in 1988 and is headquartered in Vancouver, Canada.
To learn more about Global Hunter visit: http://www.globalhunter.ca
MusclePharm Corporation (OTCQB:MSLP)
MusclePharm Corporation announced this week that its award-winning products will launch in up to 400 of the Vitamin World retail locations nationwide starting in January 2011.
The agreement starts in January and Vitamin World will introduce MusclePharm's top-selling supplements, including Assault, a popular pre-workout performance-enhancing product, and Shred Matrix, a revolutionary cutting-edge fat loss system, in its retail locations throughout the country.
Vitamin World is widely recognized as one of the top supplement retail providers in the United States and the partnership will allow MSLP an opportunity for continued growth. "We are very excited about adding more retail locations to our nationwide distribution. We know Vitamin World will be a great partner and will further spread the MusclePharm brand nationwide," MSLP President Cory Gregory said. "This new partnership with Vitamin World is a direct reflection of our fulfillment agreement and Distribution Center we recently launched with our manufacturer, which will allow us continue to grow at an impressive rate."
MSLP announced the iVitals fulfillment agreement last month and it is one that will greatly reduce backorders and improve turnaround time on all orders, allowing the company to increase its availability nationwide.
MSLP products are currently available nationwide in more than 1,200 General Nutrition Centers (NYSE:GNC), 450 Vitamin Shoppes and more than 100 online stores.
To learn more about MSLP visit: http://www.musclepharm.com
Simcere Pharmaceutical Group (NYSE:SCR) announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen"), in which Simcere holds a 52.5% controlling stake, has been found liable for producing and selling inferior quality products by the People's Court of Tianning District, Changzhou City and was sentenced to a fine of RMB4.6 million. The fine consists of penalties and confiscated revenues from previous sales of substandard human-use rabies vaccine and is in addition to the RMB25.6 million administrative fine imposed by the Changzhou Food and Drug Administration on May 17, 2010. The fines of RMB4.6 million and the administrative fines of RMB25.6 million have already been accrued in the previous financial statements. Six members of Jiangsu Yanshen's former management team were also found guilty and received individual penalties.
Simcere Pharmaceutical Group develops, manufactures, and markets branded generic pharmaceuticals in the People's Republic of China. The company's principal branded generic pharmaceuticals include edaravone injection pharmaceutical to treat strokes under the Bicun and Yidasheng brands; amoxicillin capsules, dispersible tablets, granules, and injection under the Zailin brand.
Nordion Inc. (NYSE:NDZ) announced recently, it has signed a non-binding letter of agreement with Best Medical International Inc. for the divestiture of MDS Nordion S.A. The MDS Nordion S.A. operations currently support four lines of business out of the Fleurus, Belgium location. Agiris - Non-destructive testing equipment and sources.Glucotrace - FDG imaging agent.TheraSphere - Targeted liver cancer radiotherapeutic.Radiochemical business - Generic cyclotron and reactor isotopes.
Nordion Inc., a health science company, provides products and services used for the prevention, diagnosis, and treatment of diseases. The company offers technologies for use in medical imaging and radio therapeutics; and also provides sterilization technologies. It offers medical isotopes to diagnose, monitor, and treat disease, including cardiology, oncology, and neurology; and molecular medicine services comprising discovery and pre-clinical, clinical and commercialization.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.VOB) and the Frankfurt Stock Exchange (FSE:G5D)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCQB:MSLP).